← SearchPRECLINICAL ADVANCEMENT OF NOVEL MECHANISM-OF-ACTION THERAPEUTICS TO COMBAT TYPE 2 DIABETES IN US VETERANS$4,192,268FY2019Department of the ArmyDODRidgeline Therapeutics LlcInvestigatorsView source on USAspending →